Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Impact of Evolocumab as an Additional Lipid-lowering Therapy to Changes in Lipid Core Burden Index of Non-culprit Vulnerable Plaque in Patients Who Underwent Percutaneous Coronary Intervention for the Acute Coronary Syndrome [Phase 4]
Phase 4 clinical trial evaluating evolocumab as an added lipid-lowering therapy and its impact on lipid core burden index in non-culprit vul…
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: NIRTRAKS Post-Market Study (NIRTRAKS) [NA]
Completed post-market study of NIRTRAKS in de novo stenotic lesions of native coronary arteries with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: RFR and FFR for the the Prediction of Post-PCI Results [Phase 4]
Phase 4 clinical trial update investigating fractional flow reserve (FFR) and resting full-cycle ratio (RFR) for predicting post-PCI results…
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease [Phase 4]
Phase 4 trial update on the lipid-lowering efficacy of an extended-release niacin/laropiprant combination in cardiovascular disease; the stu…
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Cardio-protective Effect of Metformin in Patients Undergoing PCI [Phase 3]
Phase 3 trial investigating whether metformin provides cardio-protective effects in patients undergoing percutaneous coronary intervention.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: Development and Translation of Generator-Produced PET Tracer for Myocardial Perfusion Imaging-Dosimetry Group [EARLY_Phase 1]
Early-phase1 clinical trial completed for a generator-produced PET tracer aimed at myocardial perfusion imaging and dosimetry in coronary ar…
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Residual Inflammatory Risk-Guided colcHicine in Elderly Trial [Phase 4]
A Phase 4 clinical trial update exploring residual inflammatory risk-guided colchicine in elderly patients undergoing percutaneous coronary …
-
CLINICAL_TRIALS trial_result · 2023-08-23Clinical Trial Update: De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS [Phase 3]
A Phase 3 trial evaluating de-escalation of antiplatelet therapy to assess platelet reactivity and outcomes in high bleeding risk patients w…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Impact of Chronic Kidney Disease on Clopidogrel Effects in Diabetes Mellitus [Phase 4]
A Phase 4 trial analyzed how chronic kidney disease affects clopidogrel in patients with type 2 diabetes, completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-08-18Clinical Trial Update: Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG [Phase 4]
Phase 4 trial update evaluating a proton pump inhibitor to prevent upper gastrointestinal injury in patients on dual antiplatelet therapy af…
-
CLINICAL_TRIALS trial_result · 2023-08-08Clinical Trial Update: Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease [Phase 4]
Phase 4 trial update on the effects of statin therapy in elderly patients with atherosclerotic cardiovascular disease.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: A Study of Flurpiridaz (18F) Injection for PET Imaging for Assessment of MPI Quality Using HPLC and SPE Manufacturing Processes [Phase 2]
Phase 2 study evaluating flurpiridaz (18F) injection for PET imaging to assess myocardial perfusion quality, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Pressure Guidewire Comparison [Phase 4]
Phase 4 clinical trial update evaluating pressure guidewire performance in coronary artery disease and myocardial ischemia.
-
CLINICAL_TRIALS trial_result · 2023-07-12Clinical Trial Update: An International Study to Evaluate Diagnostic Efficacy of Flurpiridaz (18F) Injection PET MPI in the Detection of Coronary Artery Disease (CAD) [Phase 3]
Phase 3 international trial evaluating diagnostic efficacy of Flurpiridaz (18F) injection PET MPI for detecting Coronary Artery Disease has …
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: CES1 Carriers in the PAPI Study [Phase 4]
Phase 4 clinical trial update focusing on CES1 carrier status in the PAPI study; results have been posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease [Phase 4]
A Phase 4 trial updating on the effects of trimetazidine on microcirculation after stenting in stable coronary artery disease.
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Evaluation of XTR004 as a Novel 18F-labeled PET MPI Tracer in Diagnosis of Known or Suspected CAD [Phase 2]
Phase 2 clinical trial evaluating XTR004 as an 18F-labeled PET tracer for diagnosing known or suspected coronary artery disease has complete…
-
CLINICAL_TRIALS trial_result · 2023-06-02Clinical Trial Update: Body Weight Adjusted Clopidogrel Treatment in Patients With CORonary Artery Disease [Phase 2, Phase 3]
A clinical trial update exploring body weight–adjusted clopidogrel treatment in coronary artery disease patients, spanning Phase 2 and Phase…
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: PD and PK Profiles of Switching Between Cangrelor and Ticagrelor Following Ticagrelor Pre-treatment [Phase 4]
Phase 4 trial updating the pharmacodynamics and pharmacokinetics of switching between cangrelor and ticagrelor after ticagrelor pretreatment…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: Effect of Evolocumab on Coronary Plaque Characteristics [Phase 4]
Phase 4 trial update evaluating evolocumab's effect on coronary plaque characteristics in coronary artery disease patients; results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Short-Term Exposure to Lipophilic Anti-proliferative Drugs Delivered by Angiographic Contrast Media [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating short-term exposure to lipophilic anti-proliferative drugs delivered via angiographic contrast media in …
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease [Phase 4]
A Phase 4 clinical trial update evaluating switching from DAPT to dual pathway inhibition with low-dose rivaroxaban in addition to aspirin f…
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: De-escalation of Ticagrelor in Post PPCI [Phase 1, Phase 2]
A clinical trial update on de-escalation of ticagrelor after primary percutaneous coronary intervention, spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole) [Phase 4]
Phase 4 trial update evaluating efficacy and safety of Lansoprazole for patients with Coronary Artery Disease.
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin" [Phase 4]
Phase 4 safety trial comparing ticagrelor plus warfarin versus clopidogrel plus aspirin plus warfarin in patients with atrial fibrillation a…